INSERM, U1168, Aging and chronic diseases. Epidemiological and Public health approaches, UMR-S 1168 Univ Versailles St-Quentin-en-Yvelines, F-94807, Villejuif, France.
Univ Versailles St-Quentin-en-Yvelines, UMR-S 1168, Versailles, France.
Respir Res. 2019 Sep 6;20(1):203. doi: 10.1186/s12931-019-1173-0.
High Fluorescent oxidation products level (FlOPs), a global oxidative stress biomarker, was associated cross-sectionally with poor asthma outcomes but its longitudinal association with asthma evolution has never been examined. We aimed to study the associations between FlOPs level at baseline and changes in current asthma, asthma attacks and asthma control status over 8 years. We used data from the second survey of the French EGEA cohort study as baseline and the third survey as follow-up. At baseline, the mean age of the 489 participants with ever asthma was 39 (± 16) years, 49% were women. Among participants with controlled asthma at baseline, high FlOPs level was significantly associated with worsening of asthma control at follow-up (odds-ratio adjusted for age, sex and smoking status (95% CI): 2.27 (1.32-3.90). No other significant associations were observed. In conclusion, results suggest FlOPs as a predictor of asthma evolution in adults and a good candidate marker in asthma management.
高荧光氧化产物水平(FlOPs)是一种全身性氧化应激生物标志物,与哮喘不良结局呈横断面相关,但它与哮喘演变的纵向关联从未被研究过。我们旨在研究基线 FlOPs 水平与 8 年内当前哮喘、哮喘发作和哮喘控制状况变化之间的关系。我们使用了法国 EGEA 队列研究第二阶段调查的数据作为基线,以及第三阶段调查作为随访。在基线时,489 名既往患有哮喘的参与者的平均年龄为 39(±16)岁,其中 49%为女性。在基线时哮喘得到控制的参与者中,高 FlOPs 水平与随访时哮喘控制恶化显著相关(经年龄、性别和吸烟状况调整后的比值比(95%置信区间):2.27(1.32-3.90))。没有观察到其他显著关联。总之,结果表明 FlOPs 是成人哮喘演变的预测因子,也是哮喘管理的一个潜在候选标志物。